A comparison of three tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients
Annals of Surgical Oncology2004Vol. 11(S2), pp. S51–S51
Mark B. Faries, Rajat Gupta, Xijun Ye, Chi K. Lee, Reynold Yee, Zacarias C. Leopoldo, David Elashoff, D L Morton
Related Papers
- → Resecting Lymph Nodes in Colon Cancer: More than a Staging Operation?(2007)12 cited
- → Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era(2023)11 cited
- → ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer(2022)2 cited
- → ASO Visual Abstract: Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management(2022)
- → Resecting Lymph Nodes in Colon Cancer: More than a Staging Operation?(2007)